We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Study Findings Hard to Interpret—Reply

Antoine Pariente, MD, PhD; Annie Fourrier-Réglat, PharmD, PhD; Yola Moride, PhD, FISPE
Arch Intern Med. 2012;172(18):1429-1430. doi:10.1001/archinternmed.2012.4303.
Text Size: A A A
Published online


In reply

In response to our article “Antipsychotic Use and Myocardial Infarction in Older Patients With Treated Dementia,”1 van Hout et al emphasized that patients with dementia treated with antipsychotics (APs) were more likely to receive antidepressants and anxiolytics and hence present with behavioral problems that might be related to myocardial infarction. As we have discussed, this is expected because APs are usually prescribed to patients with more severe dementia, in whom antidepressants and anxiolytics are likely to be prescribed.2 Analyses were adjusted for drugs potentially associated with advanced stages of dementia. Van Hout et al argued that it would have been important to compare classes of APs. Although, in the literature, the difference in the risk of stroke across AP classes is not demonstrated,3 we agree and underlined this limitation in the discussion. The limitation of using drug dispensing as a proxy for drug use is common to all studies based on claims data. We agree that confirmatory field studies would bring additional evidence to this first demonstration.

First Page Preview

View Large
First page PDF preview





October 8, 2012
Hein P. van Hout, PhD; Harm W. van Marwijk, MD, PhD; Johannes C. van der Wouden, PhD
Arch Intern Med. 2012;172(18):1429-1430. doi:10.1001/archinternmed.2012.3764.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
PubMed Articles

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Evidence to Support the Update

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Evidence Summary and Review 2